Anna Alyasova

9.6k total citations
31 papers, 384 citations indexed

About

Anna Alyasova is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Anna Alyasova has authored 31 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Anna Alyasova's work include Renal cell carcinoma treatment (10 papers), Renal and related cancers (6 papers) and Cancer Genomics and Diagnostics (6 papers). Anna Alyasova is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Renal and related cancers (6 papers) and Cancer Genomics and Diagnostics (6 papers). Anna Alyasova collaborates with scholars based in Russia, United States and Italy. Anna Alyasova's co-authors include Igor Bondarenko, Giada Rizzi, Richard J. Gralla, Paul J. Hesketh, Alla Lisyanskaya, Antônio Rossi, Robert J. Motzer, Anna Berkenblit, Gary D Acton and Yaroslav Shparyk and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Anna Alyasova

22 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Alyasova Russia 7 174 156 123 113 81 31 384
Terumasa Sowa Japan 13 170 1.0× 112 0.7× 114 0.9× 30 0.3× 81 1.0× 22 398
Toshiaki Iwase United States 13 42 0.2× 92 0.6× 97 0.8× 133 1.2× 114 1.4× 35 439
Yushang Cui China 10 89 0.5× 168 1.1× 105 0.9× 29 0.3× 175 2.2× 27 395
Simon Küsters Germany 10 110 0.6× 190 1.2× 91 0.7× 27 0.2× 90 1.1× 17 409
Wichit Arpornwirat Thailand 9 53 0.3× 60 0.4× 71 0.6× 29 0.3× 58 0.7× 17 279
Samantha Williams United States 8 37 0.2× 85 0.5× 53 0.4× 79 0.7× 100 1.2× 22 332
Igor Djurisic Serbia 10 130 0.7× 75 0.5× 60 0.5× 17 0.2× 73 0.9× 31 325
Jialong Li China 9 99 0.6× 61 0.4× 131 1.1× 28 0.2× 41 0.5× 34 345
Lutske Lodewijk Netherlands 9 101 0.6× 72 0.5× 56 0.5× 10 0.1× 64 0.8× 19 329
Lu-Jun Shen China 12 92 0.5× 68 0.4× 110 0.9× 57 0.5× 68 0.8× 12 345

Countries citing papers authored by Anna Alyasova

Since Specialization
Citations

This map shows the geographic impact of Anna Alyasova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Alyasova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Alyasova more than expected).

Fields of papers citing papers by Anna Alyasova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Alyasova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Alyasova. The network helps show where Anna Alyasova may publish in the future.

Co-authorship network of co-authors of Anna Alyasova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Alyasova. A scholar is included among the top collaborators of Anna Alyasova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Alyasova. Anna Alyasova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adamyan, L.V., et al.. (2024). Immunological aspects of endometriosis: pathophysiological mechanisms, diagnosis, autoimmunity, targeted therapy and modulation. Russian Journal of Human Reproduction. 30(2). 15–15. 3 indexed citations
2.
Adamyan, L.V., et al.. (2024). Benign breast diseases in the focus of proliferative pathology of the reproductive system. Russian Journal of Human Reproduction. 30(3). 33–33.
3.
Adamyan, L.V., et al.. (2024). Non-hormonal methods of treating premature ovarian insufficiency (POI). Russian Journal of Human Reproduction. 30(2). 6–6.
4.
Adamyan, L.V., Anna Alyasova, & A.A. Stepanian. (2024). Endometriosis and genital malformations in children and adolescents. What do they have in common?. Russian Journal of Human Reproduction. 30(3). 14–14.
5.
6.
Rha, Sun Young, Toni K. Choueiri, В. Б. Матвеев, et al.. (2023). Efficacy and safety of lenvatinib plus pembrolizumab vs sunitinib in the East Asian subset of patients with advanced renal cell carcinoma from the CLEAR trial. International Journal of Cancer. 153(6). 1241–1250. 3 indexed citations
7.
8.
Alyasova, Anna, et al.. (2022). Cancer-testis genes mRNA presence in tumor lesion and peripheral blood of endometrial cancer patients. Russian Journal of Biotherapy. 21(2). 33–39.
9.
Alyasova, Anna, et al.. (2020). Tumor M2-Pyruvate Kinase, Matrix Carbonic Anhydrase IX, and Metalloproteinase 9 — Novel Prognostic Markers of Renal Cell Carcinoma. Sovremennye tehnologii v medicine. 12(2). 43–43. 5 indexed citations
10.
Alyasova, Anna, et al.. (2019). The CD16A and CD16B mRNA level as potential immunological marker in colorectal cancer. SHILAP Revista de lepidopterología. 18(1). 220–227. 1 indexed citations
11.
Yang, Lin, Anna Alyasova, Dingwei Ye, et al.. (2018). RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis. BMC Cancer. 18(1). 195–195. 2 indexed citations
12.
Dudenkova, Varvara V., et al.. (2017). The level of Hydrogen Peroxide in HeLa Cells in an Ozonated Medium. Bulletin of Experimental Biology and Medicine. 163(4). 570–573. 1 indexed citations
13.
Aapro, Matti, Karin Jordan, Richard J. Gralla, et al.. (2016). Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients. Journal of Geriatric Oncology. 8(1). 56–63. 7 indexed citations
14.
Alyasova, Anna, et al.. (2015). Prognostic Value of Blood Serum Content of Soluble CD50 and CD54 Molecules in Patients with Uterine and Cervical Cancer. Sovremennye tehnologii v medicine. 7(4). 141–146. 1 indexed citations
15.
Motzer, Robert J., Anna Alyasova, А. А. Карпенко, et al.. (2015). Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4). Annals of Oncology. 27(3). 441–448. 33 indexed citations
16.
17.
Vv, Novikov, et al.. (2014). The Content of Soluble HLA Class I and HLA -DR Molecules in Serum in Patients with Uterine Cervix and Body Pathology. 6. 1 indexed citations
18.
Alyasova, Anna, et al.. (2014). The content of oligomeric and total fractions of soluble CD38 molecules in blood serum of patients with hysteromyoma. 6. 1 indexed citations
19.
20.
Alyasova, Anna, et al.. (2013). Integral Analysis of Blood Plasma Biochemical Parameters as an Optimizing Diagnostic Technique of Epithelial Tissue Malignant Neoplasms. 5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terumasa Sowa Breakdown of academic impact, for papers by Toshiaki Iwase Breakdown of academic impact, for papers by Yushang Cui Breakdown of academic impact, for papers by Simon Küsters Breakdown of academic impact, for papers by Wichit Arpornwirat Breakdown of academic impact, for papers by Samantha Williams Breakdown of academic impact, for papers by Igor Djurisic Breakdown of academic impact, for papers by Jialong Li Breakdown of academic impact, for papers by Lutske Lodewijk Breakdown of academic impact, for papers by Lu-Jun Shen
Rankless by CCL
2026